Quinoa saponins alleviate high-fat diet/streptozotocin-induced insulin resistance in mice by regulating endoplasmic reticulum stress

Quinoa ( Chenopodium quinoa Willd.) contains abundant saponin-type constituents, yet the antidiabetic efficacy of quinoa saponin-enriched fractions and their molecular basis remain unclear. Herein, a quinoa ethanol extract was fractionated on D101 macroporous resin to yield 60%, 80% and 100% ethanol eluates (60%ECQG, 80%ECQG and 100%ECQG), and their metabolic benefits were evaluated in high-fat diet/streptozotocin (HFD/STZ)-induced type 2 diabetes mellitus (T2DM) mice. Compositional analysis showed that 60%ECQG was flavonoid-enriched, whereas 80%ECQG and 100%ECQG were saponin-enriched, with 100%ECQG containing the highest total saponin content. UPLC-Q-TOF/MS profiling of 80%ECQG tentatively annotated 32 constituents, including 28 triterpenoid saponins. In the initial efficacy screening, quinoa saponin administration, particularly 80%ECQG and 100%ECQG, significantly reduced fasting blood glucose and homeostasis model assessment of insulin resistance (HOMA-IR), improved glucose tolerance and insulin sensitivity, ameliorated serum and hepatic lipid abnormalities, alleviated hepatic oxidative stress, and mitigated hepatic steatosis, hepatocellular injury and pancreatic islet damage. Based on its robust metabolic efficacy and high saponin enrichment, 100%ECQG was selected as a representative saponin-enriched fraction for mechanistic validation. In an independent cohort, 100%ECQG at 100 and 200 mg/kg reproducibly ameliorated metabolic abnormalities and tissue injury, with an overall stronger response at the higher dose. These effects were accompanied by changes in hepatic IRS-1/PI3K/Akt/GLUT4/GSK-3β signaling, modulation of the Nrf2/Keap1/HO-1 antioxidant response, and altered PERK/IRE1/ATF6-associated endoplasmic reticulum (ER) stress. Collectively, these findings demonstrate the antidiabetic potential of saponin-enriched quinoa fractions and suggest that the protective effects of 100%ECQG are associated with coordinated regulation of hepatic insulin signaling, redox homeostasis, and ER stress.

Authors

Institutions

Publication Details

Journal
Industrial Crops and Products
Published
2026-11-21
DOI
https://doi.org/10.1016/j.indcrop.2026.124823
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Quinoa saponins alleviate high-fat diet/streptozotocin-induced insulin resistance in mice by regulating endoplasmic reticulum stress

Fangfang Tie, Qi Zheng Dong, LiZhen Song, Na Hu et al.
Industrial Crops and Products
Natural Antidiabetic Agents Studies
article

Quinoa saponins alleviate high-fat diet/streptozotocin-induced insulin resistance in mice by regulating endoplasmic reticulum stress

Fangfang Tie, Qi Zheng Dong, LiZhen Song, Na Hu, Nixia Tan, Honglun Wang
article en

Abstract

Quinoa ( Chenopodium quinoa Willd.) contains abundant saponin-type constituents, yet the antidiabetic efficacy of quinoa saponin-enriched fractions and their molecular basis remain unclear. Herein, a quinoa ethanol extract was fractionated on D101 macroporous resin to yield 60%, 80% and 100% ethanol eluates (60%ECQG, 80%ECQG and 100%ECQG), and their metabolic benefits were evaluated in high-fat diet/streptozotocin (HFD/STZ)-induced type 2 diabetes mellitus (T2DM) mice. Compositional analysis showed that 60%ECQG was flavonoid-enriched, whereas 80%ECQG and 100%ECQG were saponin-enriched, with 100%ECQG containing the highest total saponin content. UPLC-Q-TOF/MS profiling of 80%ECQG tentatively annotated 32 constituents, including 28 triterpenoid saponins. In the initial efficacy screening, quinoa saponin administration, particularly 80%ECQG and 100%ECQG, significantly reduced fasting blood glucose and homeostasis model assessment of insulin resistance (HOMA-IR), improved glucose tolerance and insulin sensitivity, ameliorated serum and hepatic lipid abnormalities, alleviated hepatic oxidative stress, and mitigated hepatic steatosis, hepatocellular injury and pancreatic islet damage. Based on its robust metabolic efficacy and high saponin enrichment, 100%ECQG was selected as a representative saponin-enriched fraction for mechanistic validation. In an independent cohort, 100%ECQG at 100 and 200 mg/kg reproducibly ameliorated metabolic abnormalities and tissue injury, with an overall stronger response at the higher dose. These effects were accompanied by changes in hepatic IRS-1/PI3K/Akt/GLUT4/GSK-3β signaling, modulation of the Nrf2/Keap1/HO-1 antioxidant response, and altered PERK/IRE1/ATF6-associated endoplasmic reticulum (ER) stress. Collectively, these findings demonstrate the antidiabetic potential of saponin-enriched quinoa fractions and suggest that the protective effects of 100%ECQG are associated with coordinated regulation of hepatic insulin signaling, redox homeostasis, and ER stress.

Industrial Crops and ProductsVol. 254
Qinghai University (CN), Chinese Academy of Sciences (CN), Northwest Institute of Plateau Biology (CN)
Natural Antidiabetic Agents Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon